| 05/08/2026 6:40 AM | Criteo (1576427) Filer | Form DEFA14A | |
| 05/08/2026 6:34 AM | Criteo (1576427) Filer | Form DEF 14A | |
| 05/08/2026 6:35 AM | Criteo (1576427) Filer | Form DEFA14A | |
| 05/08/2026 6:37 AM | Criteo (1576427) Filer | Form DEFA14A | |
| 05/06/2026 3:01 PM | Criteo (1576427) Subject | Form 425 | |
| 05/06/2026 6:05 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 3:15 PM | Criteo (1576427) Filer | Form PRE 14A | |
| 04/28/2026 3:19 PM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 7:46 AM | Criteo (1576427) Issuer van der Kooi Frederik (1981335) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 3:07 PM | Criteo (1576427) Issuer Glickman Sarah JS (1749338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 3:08 PM | Criteo (1576427) Issuer Damon Ryan (1769573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CRTO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Criteo and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/03/2026 3:00 PM | Criteo (1576427) Subject Glickman Sarah JS (1749338) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 5:47 PM | Criteo (1576427) Subject Glickman Sarah JS (1749338) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 5:50 PM | Criteo (1576427) Subject Damon Ryan (1769573) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:20 PM | Criteo (1576427) Issuer Komasinski Michael (2056554) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:21 PM | Criteo (1576427) Issuer Damon Ryan (1769573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:23 PM | Criteo (1576427) Issuer Glickman Sarah JS (1749338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/27/2026 7:10 AM | Criteo (1576427) Subject | Form 425 | |
| 02/27/2026 7:06 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:23 PM | Criteo (1576427) Subject Damon Ryan (1769573) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:31 AM | Criteo (1576427) Subject | Form 425 | |
| 02/17/2026 7:35 AM | Criteo (1576427) Filer | Form DEFA14A | |
| 02/11/2026 11:51 AM | Criteo (1576427) Subject MORGAN STANLEY (895421) Filed by | Form SCHEDULE 13G/A | |
| 02/11/2026 6:11 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/22/2026 6:00 AM | Criteo (1576427) Filer | Form 424B3 | |
| 01/22/2026 6:10 AM | Criteo (1576427) Subject | Form 425 | |
| 01/22/2026 6:15 AM | Criteo (1576427) Subject | Form 425 | |
| 01/21/2026 11:15 PM | Criteo (1576427) Filer | Form EFFECT | |
| 01/07/2026 7:08 AM | Criteo (1576427) Subject | Form 425 | |
| 01/07/2026 6:35 AM | Criteo (1576427) Filer | Form POS AM | |
| 01/07/2026 6:12 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 6:13 AM | Criteo (1576427) Subject | Form 425 | |
| 12/19/2025 3:07 PM | Criteo (1576427) Issuer Damon Ryan (1769573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:31 PM | Criteo (1576427) Subject | Form 425 | |
| 12/08/2025 3:08 PM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/24/2025 3:23 PM | Criteo (1576427) Issuer Damon Ryan (1769573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 3:24 PM | Criteo (1576427) Issuer Glickman Sarah JS (1749338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 12:40 PM | CADIAN CAPITAL MANAGEMENT, LP (1423686) Filed by Criteo (1576427) Subject | Form SCHEDULE 13G/A | |
| 11/12/2025 7:23 AM | Criteo (1576427) Issuer van der Kooi Frederik (1981335) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 3:25 PM | Criteo (1576427) Issuer Lalleman Marie (1775027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 3:27 PM | Balla Nathalie (1711277) Reporting Criteo (1576427) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad) A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide.
On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033. Read the full report on this small-cap peptide company now |
| 11/04/2025 4:01 PM | Criteo (1576427) Issuer TEUNISSEN ERNST 02494 (1506375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/29/2025 4:07 PM | Criteo (1576427) Subject | Form 425 | |
| 10/29/2025 3:08 PM | Criteo (1576427) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/29/2025 6:19 AM | Criteo (1576427) Subject | Form 425 | |
| 10/29/2025 6:21 AM | Criteo (1576427) Subject | Form 425 | |
| 10/29/2025 6:12 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/29/2025 6:14 AM | Criteo (1576427) Subject | Form 425 | |
| 10/29/2025 6:18 AM | Criteo (1576427) Subject | Form 425 | |
| 08/26/2025 3:05 PM | Criteo (1576427) Issuer Damon Ryan (1769573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2025 3:06 PM | Criteo (1576427) Issuer Glickman Sarah JS (1749338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 4:12 PM | Criteo (1576427) Subject Damon Ryan (1769573) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2025 3:37 PM | Criteo (1576427) Subject Glickman Sarah JS (1749338) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2025 5:23 PM | BARCLAYS PLC (312069) Filed by Criteo (1576427) Subject | Form SCHEDULE 13G | |
| 07/31/2025 7:27 AM | Criteo (1576427) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/30/2025 6:13 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/28/2025 4:43 PM | Criteo (1576427) Subject Gleason Brian (2030204) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2025 7:04 AM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 3:21 PM | Criteo (1576427) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 3:24 PM | Criteo (1576427) Issuer Jay Stefanie (1849124) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/28/2025 3:08 PM | Criteo (1576427) Issuer Glickman Sarah JS (1749338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2025 3:09 PM | Criteo (1576427) Issuer Gleason Brian (2030204) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2025 3:11 PM | Criteo (1576427) Issuer Damon Ryan (1769573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:08 PM | Criteo (1576427) Subject Gleason Brian (2030204) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |